MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
99.00
+0.14 (+0.14%)
At close: 4:00PM EDT

99.00 0.00 (0.00%)
After hours: 4:43PM EDT

Stock chart is not supported by your current browser
Previous Close98.86
Open99.01
Bid98.70 x 800
Ask99.62 x 1200
Day's Range98.73 - 99.65
52 Week Range76.41 - 99.65
Volume5,694,330
Avg. Volume4,650,346
Market Cap133.7B
Beta0.70
PE Ratio (TTM)42.69
EPS (TTM)2.32
Earnings DateNov 20, 2018
Forward Dividend & Yield2.00 (2.06%)
Ex-Dividend Date2018-09-27
1y Target Est102.65
Trade prices are not sourced from all markets
  • Under Armour, American Airlines and Medtronic are the Yahoo Finance charts of the day.
    Yahoo Finance Video4 days ago

    Under Armour, American Airlines and Medtronic are the Yahoo Finance charts of the day.

    Let's check out the Yahoo Finance charts of the day. Under Armour (UA): Shares are up in early trade, at around 2.7%.  J.P. Morgan upgraded Under Armour stock to "neutral" from "underweight". The firm said it believed the athletic apparel maker will meet consensus earnings estimates for fiscal 2018-2019.  American Airlines (AAL): Shares up here, 2.9%.  The airline is the latest to raise their checked bag fee by $5 joining United Continental, Delta Airlines and Jet Blue. The first checked bag will be $30 and the second bag will be $40. Medtronic (MDT): Shares down here, around .24%.  Medtronic has reached a deal to acquire medical device maker Mazor Robotics for about $1.64 billion in cash. The company is focused on strengthening its provision of technology for robotic-assisted spine surgeries. For more on today's big stock movers check out the Final Round, live at 3:30 p.m. ET, right here on Yahoo Finance.

  • Medtronic seeks to patent color-changing skin patch to measure glucose in sweat
    American City Business Journals3 hours ago

    Medtronic seeks to patent color-changing skin patch to measure glucose in sweat

    The medical-device giant is pursuing the patent as companies and researchers nationwide angle to develop painless techniques for measuring and tracking glucose levels in diabetes patients. Medtronic's idea would change color based on glucose levels and could heat the skin for insufficiently sweaty patients.

  • 8 Long-Term Investments to Give Your Grandchildren
    InvestorPlace8 hours ago

    8 Long-Term Investments to Give Your Grandchildren

    Sensible investors years ago could have chosen market leaders like Polaroid, General Motors (NYSE:GM), Sears (NASDAQ:SHLD), and myriad other ‘safe’, seemingly dominant stocks that would go on to stumble badly — or even go bankrupt. It’s far from guaranteed, however, that even torrid growth will produce much in the way of long-term returns relative to the stocks’ current prices.

  • Medtronic Launches the Infinity(TM) OCT Spinal System
    GlobeNewswire10 hours ago

    Medtronic Launches the Infinity(TM) OCT Spinal System

    September 25, 2018 - Medtronic plc (MDT) today announced the U.S. launch of the Infinity(TM) Occipitocervical-Upper Thoracic (OCT) System designed to simplify posterior cervical spine surgery. The Infinity OCT System is a complete procedural solution that integrates navigation and biologics with Medtronic`s comprehensive devices and instrumentation to create efficiency in fusion procedure workflows for the upper back and neck. The announcement was made during the North American Spine Society meeting taking place from September 26th - 29th in Los Angeles where Medtronic is exhibiting at Booth #1201.

  • Top Stock Reports for Boeing, NVIDIA & Medtronic
    Zacksyesterday

    Top Stock Reports for Boeing, NVIDIA & Medtronic

    Top Stock Reports for Boeing, NVIDIA & Medtronic

  • Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients
    GlobeNewswireyesterday

    Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients

    September 24, 2018 - Medtronic plc (MDT), a global leader in heart valve therapies, today announced new data presented at the 30th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation. Over the weekend, investigators presented the longest-term data to-date from the CoreValve U.S. Pivotal Trial, in addition to the complete two-year outcomes from the SURTAVI trial, which confirmed the excellent outcomes previously predicted in aortic stenosis patients at intermediate surgical risk.

  • Investor's Business Daily4 days ago

    Stocks, Oil Prices Rise: Acuity Upgraded, McDonald's Hikes Dividend

    China stocks were early movers Friday, as McDonald's topped the Dow and Mazor Robotics spiked on takeover news. Micron Technology dragged chip stocks lower.

  • Better Buy: Intuitive Surgical, Inc. vs. Medtronic plc
    Motley Fool2 days ago

    Better Buy: Intuitive Surgical, Inc. vs. Medtronic plc

    The robotic surgery kingpin versus a medical device titan: Which one is the better bet for new money today?

  • Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES
    GlobeNewswire3 days ago

    Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES

    September 22, 2018 - Investigators today unveiled new clinical data from the physician-initiated BIONYX study, representing the first all-comers analysis in nearly 2,500 patients comparing the safety and efficacy of the durable polymer Resolute Onyx(TM) drug-eluting stent (DP-DES) from Medtronic plc (MDT) to the Orsiro biodegradable polymer stent (BP-DES). At one year, the study showed patients with coronary artery disease who were treated with Orsiro BP-DES received no clinical advantage compared to patients treated with the Resolute Onyx DP-DES, and Orsiro BP-DES demonstrated a higher rate of stent thrombosis.1 Published simultaneously in The Lancet, the results were presented today during a Late-Breaking Clinical Trial session at the 30th Transcatheter Cardiovascular Therapeutics conference (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.

  • 4 Days Left Until Medtronic plc (NYSE:MDT) Trades Ex-Dividend,
    Simply Wall St.3 days ago

    4 Days Left Until Medtronic plc (NYSE:MDT) Trades Ex-Dividend,

    Investors who want to cash in on Medtronic plc’s (NYSE:MDT) upcoming dividend of US$0.50 per share have only 4 days left to buy the shares before its ex-dividend date, 27Read More...

  • CNBC4 days ago

    Cramer's lightning round: Don't get speculative with oil and gas stocks

    It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Notice how FedEx has come right back even though it was supposed to be such a disappointing quarter. ActionAlerts, my charitable trust, has others, but they may be too so-called go-go for you.

  • Cramer's lightning round: Don't get speculative with oil and gas stocks
    CNBC4 days ago

    Cramer's lightning round: Don't get speculative with oil and gas stocks

    Jim Cramer zooms through his take on callers' favorite stocks, including a small independent energy play that he wouldn't recommend to investors.

  • What Happened in the Stock Market Today
    Motley Fool4 days ago

    What Happened in the Stock Market Today

    On a mixed day for the major benchmarks, Medtronic announced plans to buy Mazor Robotics, and Micron Technology beat expectations for its latest quarter.

  • Why Medtronic Is Buying This Growing Robotics Company
    Motley Fool4 days ago

    Why Medtronic Is Buying This Growing Robotics Company

    Medtronic's collaboration with Mazor Robotics has resulted in an outright acquisition.

  • Is Medtronic Paying Too Much for Mazor Robotics?
    Motley Fool4 days ago

    Is Medtronic Paying Too Much for Mazor Robotics?

    This medical-device titan is paying up to swallow the robotic-surgery upstart whole. Does the deal make sense?

  • Under Armour posting higher, American Airlines on an upswing, Medtronic dips
    Yahoo Finance4 days ago

    Under Armour posting higher, American Airlines on an upswing, Medtronic dips

    Under Armour, American Airlines and Medtronic are the Yahoo Finance charts of the day.

  • Mazor Robotics Stock Soars on Medtronic Deal
    InvestorPlace4 days ago

    Mazor Robotics Stock Soars on Medtronic Deal

    The deal will have Medtronic acquiring Mazor Robotics (OTCMKTS:MZRTF) for $1.64 billion. It will be doing this by purchasing all outstanding shares of Mazor Robotics stock for $58.50 per American Depository Share, or $29.25 per ordinary share. Medtronic says that it will be using cash to fund its acquisition of Mazor Robotics stock.

  • GlobeNewswire4 days ago

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Mazor Robotics, Inc. to Medtronic plc is Fair to Shareholders

    NEW YORK, Sept. 21, 2018-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All Persons or Entities who purchased Mazor Robotics, Inc. stock prior to September 20, 2018. You are hereby ...

  • Stocks - Micron Sinks in Pre-market; Wells Fargo, Tesla Fall; Apple, Walmart Gain
    Investing.com4 days ago

    Stocks - Micron Sinks in Pre-market; Wells Fargo, Tesla Fall; Apple, Walmart Gain

    Investing.com - Stocks in focus in pre-market trade Friday:

  • Here's Why Mazor Robotics Is Soaring Today
    Motley Fool4 days ago

    Here's Why Mazor Robotics Is Soaring Today

    Shares jump after the company accepts a buyout offer. Here's what investors need to know.

  • Medtronic to Buy Mazor Robotics for Robotic Spine Surgery
    Zacks4 days ago

    Medtronic to Buy Mazor Robotics for Robotic Spine Surgery

    The consolidation will combine Medtronic's (MDT) spine implants, navigation and intra-operative imaging technology with Mazor Robotics' robotic-assisted surgery (RAS) systems.

  • The Wall Street Journal4 days ago

    [$$] Stocks to Watch: Micron, Alphabet, Medtronic, Adobe Systems, Wells Fargo, United Natural Foods, General Electric, Eventbrite, MDC Partners

    Here are some of the companies with shares expected to trade actively in Friday’s session. Check back closer to the market open for an updated list. Micron Technology Inc.—Down 2.7%: The memory chip maker issued a disappointing forecast with its fiscal fourth-quarter report, expecting revenue for the quarter ending in November to grow by its slowest rate in two years.

  • Benzinga4 days ago

    The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding

    The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 20.) Abbott Laboratories (NYSE: ABT ) Acceleron ...

  • Abbott Laboratories’ 379th Consecutive Quarterly Dividend
    Market Realist4 days ago

    Abbott Laboratories’ 379th Consecutive Quarterly Dividend

    On September 13, Abbott Laboratories (ABT) announced its 379th consecutive quarterly dividend, which is payable on November 15. The dividend of $0.28 per share will be paid to shareholders of record as of the close of business on October 15. The company’s annual dividend in 2017 was $1.06, while its indicated annual dividend for 2018 is $1.12 per share. Last year, it paid a quarterly dividend of $0.265 to its shareholders, so its new quarterly dividend represents an increase of ~5.7%.

  • Reuters4 days ago

    Deals of the day-Mergers and acquisitions

    Sept 21 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Friday: ** Adobe Systems Inc has agreed to buy Marketo Inc for $4.75 billion from private equity ...